share_log

HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $26

HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $26

HC Wainwright & Co.維持對MediWound的買入,將目標價上調至26美元
Benzinga ·  2023/09/21 08:24

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MediWound (NASDAQ:MDWD) with a Buy and raises the price target from $23 to $26.

HC Wainwright&Co.分析師Swayampakula Ramakanth維持MediWound(納斯達克代碼:MDWD)的買入,並將目標價從23美元上調至26美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論